Orient Europharma Co., Ltd.(TW:4120)
NT$44.90+0.55 (+1.24%)
TW:4120
Orient Europharma Co., Ltd. Revenue
NT$44.90
At close:+0.55 (+1.24%)
Orient Europharma Co., Ltd. (4120) Revenue
Orient Europharma Co., Ltd. Revenue
Orient Europharma Co., Ltd. had a revenue of 1.19B in the quarter ending Jun 30, 2026, with 3.31%. This bring the company's revenue in the last twelve months to 4.65B, Increased 1.37%. In the fiscal year ending Dec 31, 2025, Orient Europharma Co., Ltd. had annual revenue of 4.60B with 4.64% growth.
- Revenue (ttm)
- 4.65B
- Revenue Growth
- 3.77%
- P/S Ratio
- 0.84
- Revenue/Employee
- TWD 13,554,873
- Employees
- 339
- Market Cap
- TWD 3.85B
Revenue Chart
Orient Europharma Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.60B | 203.80M | 4.64% |
| Dec 31, 2024 | 4.39B | -200.59M | -4.37% |
| Dec 31, 2023 | 4.59B | -138.56M | -2.93% |
| Dec 31, 2022 | 4.73B | -36.57M | -0.77% |
| Dec 31, 2021 | 4.77B | -616.63M | -11.45% |
| Dec 31, 2020 | 5.38B | -709.60M | -11.65% |
| Dec 31, 2019 | 6.09B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.